The role of low-income and middle-income country prisons in eliminating hepatitis C,The Lancet Public Health

当前位置： X-MOL 学术 › Lancet Public Health › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The role of low-income and middle-income country prisons in eliminating hepatitis C
The Lancet Public Health ( IF 25.4 ) Pub Date : 2022-06-29 , DOI: 10.1016/s2468-2667(22)00119-0
Matthew J Akiyama ₁ , Nadine Kronfli ₂ , Joaquin Cabezas ₃ , Yumi Sheehan ₄ , Andrew Scheibe ₅ , Taha Brahni ₆ , Kunal Naik ₇ , Pelmos Mashabela ₈ , Polin Chan ₉ , Niklas Luhmann ₉ , Andrew R Lloyd ₄ ,

Affiliation

Department of Medicine, Divisions of General Internal Medicine and Infectious Diseases, Albert Einstein College of Medicine/Montefiore Medical Center, New York 10467, NY, USA.
Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University, Montreal, QC, Canada.
Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Santander, Spain; Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain.
Viral Immunology Systems Program, Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
TB HIV Care, Cape Town, South Africa; Community Oriented Primary Care research unit, Department of Family Medicine, University of Pretoria, Pretoria, South Africa.
Association de Lutte Contre le Sida, Casablanca, Morocco.
Prévention Information et Lutte Contre le SIDA, Port Louis, Mauritius.
National Department of Correctional Services, Pretoria, South Africa.
WHO Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, WHO, Geneva, Switzerland.